Nationwide Fund Advisors decreased its position in Varian Medical Systems, Inc. (NYSE:VAR) by 3.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 375,197 shares of the medical equipment provider’s stock after selling 14,419 shares during the quarter. Nationwide Fund Advisors owned about 0.41% of Varian Medical Systems worth $37,542,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Varian Medical Systems by 1.7% in the second quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock valued at $944,980,000 after buying an additional 150,482 shares during the period. BlackRock Inc. lifted its holdings in shares of Varian Medical Systems by 6.6% in the second quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock valued at $869,233,000 after buying an additional 523,858 shares during the period. First Eagle Investment Management LLC lifted its holdings in shares of Varian Medical Systems by 0.8% in the second quarter. First Eagle Investment Management LLC now owns 4,679,471 shares of the medical equipment provider’s stock valued at $482,875,000 after buying an additional 38,005 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Varian Medical Systems by 1,545.7% in the second quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock valued at $387,450,000 after buying an additional 3,526,571 shares during the period. Finally, Fiera Capital Corp lifted its holdings in shares of Varian Medical Systems by 12.0% in the second quarter. Fiera Capital Corp now owns 2,519,976 shares of the medical equipment provider’s stock valued at $260,037,000 after buying an additional 269,633 shares during the period. Institutional investors and hedge funds own 99.15% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/11/24/varian-medical-systems-inc-var-shares-sold-by-nationwide-fund-advisors.html.

Several analysts have recently weighed in on the company. BTIG Research lowered Varian Medical Systems from a “buy” rating to a “neutral” rating in a report on Thursday, September 7th. They noted that the move was a valuation call. BidaskClub upgraded Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Saturday, August 12th. Citigroup Inc. upped their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 target price on shares of Varian Medical Systems in a report on Friday, September 1st. Finally, Robert W. Baird reaffirmed a “hold” rating and set a $99.00 target price on shares of Varian Medical Systems in a report on Monday, August 28th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company’s stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average target price of $97.83.

In related news, EVP Kolleen T. Kennedy sold 931 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $105.00, for a total transaction of $97,755.00. Following the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at $2,890,755. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Dow R. Wilson sold 15,059 shares of the company’s stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $105.41, for a total value of $1,587,369.19. Following the transaction, the insider now directly owns 81,835 shares in the company, valued at $8,626,227.35. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,761 shares of company stock valued at $4,447,864. 0.91% of the stock is currently owned by company insiders.

Shares of Varian Medical Systems, Inc. (NYSE VAR) traded up $0.39 during midday trading on Friday, hitting $108.79. The stock had a trading volume of 589,000 shares, compared to its average volume of 870,540. Varian Medical Systems, Inc. has a twelve month low of $76.94 and a twelve month high of $110.23. The stock has a market capitalization of $9,987.02, a P/E ratio of 28.86, a price-to-earnings-growth ratio of 3.20 and a beta of 0.65. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.13 and a current ratio of 1.41.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million for the quarter, compared to analysts’ expectations of $741.69 million. During the same period in the prior year, the company earned $1.03 earnings per share. The company’s revenue for the quarter was down 1.1% on a year-over-year basis. research analysts anticipate that Varian Medical Systems, Inc. will post 4.26 earnings per share for the current fiscal year.

Varian Medical Systems Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.